Featured Research

from universities, journals, and other organizations

Teaching hospital status associated with death rate after colon surgery

Date:
April 19, 2010
Source:
JAMA and Archives Journals
Summary:
When both cancer and benign diagnoses are taken into consideration, patients undergoing colon surgery appear to have increased odds of death if their procedure is performed at a teaching hospital, according to a new article.

When both cancer and benign diagnoses are taken into consideration, patients undergoing colon surgery appear to have increased odds of death if their procedure is performed at a teaching hospital, according to a report in the April issue of Archives of Surgery.

"Teaching hospitals are responsible for training surgical residents and fellows in the United States, which requires a considerable allocation of resources from the federal government and a large capital outlay to offset the costs of training," the authors write as background information in the article. Although the involvement of trainees in care has raised concerns about possible negative outcomes, teaching hospitals are attractive to patients undergoing complex surgeries because they also typically possess board-certified specialty surgeons, multidisciplinary teams and intensive care unit staffing. "There is a growing interest in the interaction between teaching hospital status and volume and the individual and combined effects of these characteristics on outcomes."

"In contrast to complex procedures performed at teaching hospitals, colon surgery is more commonly performed by general surgeons in non-teaching hospitals and comparatively less sophisticated settings," write Awori J. Hayanga, M.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and the University of Michigan Medical School, Ann Arbor, and colleagues. The researchers analyzed data from 115,250 patients who underwent colon resection (removal of part of the organ) for both benign and malignant diseases at 1,045 hospitals in 38 states from 2001 through 2005.

Fewer patients had surgery at teaching hospitals than at non-teaching hospitals (46,656 vs. 68,589). The average length of hospital stay was 10 days, and 4,371 patients (3.8 percent) died in the hospital. Teaching hospitals were associated with an increased length of stay (0.5 days) and also an increased risk of death in the hospital compared with non-teaching hospitals (3.9 percent vs. 3.7 percent).

"While the volume-outcome relationship may favor colon cancer resections performed in teaching hospitals, this advantage might be lost when benign colon disease is factored into the equation," the authors write. "The inclusion of common benign disease might represent the tipping point at which both superior level of care and high volume shift away from teaching hospitals in favor of non-teaching hospital settings. Where teaching hospitals perform surgery in comparatively lower volume, they may also demonstrate comparatively poorer outcomes."

The analysis suggests that both procedure and diagnosis should be taken into account when assessing quality of care and surgical outcomes, the authors note. "As policymakers strive to establish quality measures and rationale for regionalization of surgical care, data gathered in this manner may be of great interest to patients, payers and health care providers," they conclude. "These data might further allow the identification of a similar tipping point in other gastrointestinal surgical disease that allows a demarcation to guide the venues where individual surgical care may be most appropriately and efficiently rendered."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hayanga et al. Teaching Hospital Status and Operative Mortality in the United States: Tipping Point in the Volume-Outcome Relationship Following Colon Resections? Archives of Surgery, 2010; 145 (4): 346 DOI: 10.1001/archsurg.2010.24

Cite This Page:

JAMA and Archives Journals. "Teaching hospital status associated with death rate after colon surgery." ScienceDaily. ScienceDaily, 19 April 2010. <www.sciencedaily.com/releases/2010/04/100419162127.htm>.
JAMA and Archives Journals. (2010, April 19). Teaching hospital status associated with death rate after colon surgery. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100419162127.htm
JAMA and Archives Journals. "Teaching hospital status associated with death rate after colon surgery." ScienceDaily. www.sciencedaily.com/releases/2010/04/100419162127.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins